Skip to main content

EULAV Asset Management

SEC CIK
0001540826
Latest filing
Jul 29, 2026

DXCM holding history

Dexcom Inc in every 13F filed by EULAV Asset Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DXCM overviewAll 13F holders of DXCMFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of DXCM by EULAV Asset Management, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−27,000−100.0%Sold outHolders
Q3 202527,000$1.82M<0.1%−16−0.1%ReducedHolders
Q2 202527,016$2.36M0.1%+10.0%AddedHolders
Q1 202527,015$1.84M<0.1%−21,985−44.9%ReducedHolders
Q4 202449,000$3.81M0.1%−32,000−39.5%ReducedHolders
Q3 202481,000$5.43M0.1%+5,986+8.0%AddedHolders
Q2 202475,014$8.51M0.2%−13,999−15.7%ReducedHolders
Q1 202489,013$12.3M0.3%−8,987−9.2%ReducedHolders
Q4 202398,000$12.2M0.4%−2,000−2.0%ReducedHolders
Q3 2023100,000$9.33M0.3%+21,938+28.1%AddedHolders
Q2 202378,062$10.0M0.4%−10,938−12.3%ReducedHolders
Q1 202389,000$10.3M0.4%+3,000+3.5%AddedHolders
Q4 202286,000$9.74M0.4%−36,000−29.5%ReducedHolders
Q3 2022122,000$9.83M0.4%+10,000+8.9%AddedHolders
Q2 2022112,000$8.35M0.3%+36,000+47.4%AddedConverted for a 4-for-1 splitHolders
Q1 202219,000$9.72M0.3%−6,000−24.0%ReducedHolders
Q4 202125,000$13.4M0.3%−14,000−35.9%ReducedHolders
Q3 202139,000$21.3M0.6%−12,000−23.5%ReducedHolders
Q2 202151,000$21.8M0.6%+10,000+24.4%AddedHolders
Q1 202141,000$14.7M0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.